{"retracted":false,"update":{"timestamp":1406851200000,"doi":"10.1016/j.parkreldis.2014.03.025","type":"erratum"},"doi":"10.1016/j.parkreldis.2013.07.009","journal":"Parkinsonism & Related Disorders","publisher":"Elsevier BV","title":"Corrigendum to “The efficacy and safety of ropinirole prolonged release tablets as adjunctive therapy in Chinese subjects with advanced Parkinson’s disease: A multicenter, double-blind, randomized, placebo-controlled study” [Parkinsonism and Related Disorders 19 (2013) 1022–1026]"}
